Questcor shares jump on 2Q financial results - BusinessWeek PDF Print
BusinessWeek
As a result, the company is expanding its nephrology selling effort, he added. Meanwhile, the company disclosed that it has identified that Acthar has a strong therapeutic and commercial potential as a treatment for systemic lupus erythematosus and

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.